Latest On Bellicum Pharmaceuticals, Inc (BLCM):
About Bellicum Pharmaceuticals, Inc (BLCM):
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of solid tumors expressing the prostate stem cell antigen; and BPX-603, a dual-switch GoCAR-T product candidate that is in Phase 1/2 clinical trials to treat solid tumors that express the human epidermal growth factor receptor 2 antigens. It has collaboration and license agreements with Adaptimmune Therapeutics plc, Agensys, Inc., BioVec Pharma, Inc., ARIAD Pharmaceuticals, Inc., and Baylor College of Medicine. Bellicum Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Houston, Texas.
General
- Name Bellicum Pharmaceuticals, Inc
- Symbol BLCM
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 107
- Last Split Factor1:10
- Last Split Date2020-02-06
- Fiscal Year EndDecember
- IPO Date2014-12-18
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.bellicum.com
Valuation
- Price/Sales (Trailing 12 Mt.) 4.27
- Price/Book (Most Recent Quarter) 40.34
- Enterprise Value Revenue 0.48
- Enterprise Value EBITDA 0.05
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$2.40
- Operating Margin -1057%
- Return on Assets -35%
- Revenue 5.13 million
- Earnings Per Share -$2.31
- Revenue Per Share $1.02
- Gross Profit -55328000
- Quarterly Earnings Growth -64.7%
Highlights
- Market Capitalization 25.07 million
- EBITDA -92547000
- Analyst Target Price $4.5
- Book Value Per Share $0.25
Share Statistics
- Shares Outstanding 6.1 million
- Shares Float 4.1 million
- % Held by Insiders 32%
- % Held by Institutions 23.9%
- Shares Short 689053
- Shares Short Prior Month 603899
- Short Ratio 0.49
- Short % of Float 11%
- Short % of Shares Outstanding 11%
Technicals
- Beta 1.78
- 52 Week High $9.56
- 52 Week Low $2.62
- 50 Day Moving Average 4.7
- 200 Day Moving Average 4.62
Dividends
- Dividend Date 2020-02-06
- ExDividend Date N/A
- Dividend Yield 0%
Bellicum Pharmaceuticals, Inc (BLCM) Dividend Calendar:
BLCM's last dividend payment was made to shareholders on February 6, 2020.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Bellicum Pharmaceuticals, Inc (BLCM) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-09-30 | 2020-11-05 | $N/A | -$0.18 | -$3.15 | 94.28% |
2020-06-30 | 2020-08-06 | $N/A | -$8.55 | -$2.87 | -197.91% |
2020-03-31 | 2020-05-07 | $N/A | $1.09 | -$2.73 | 139.93% |
2019-12-31 | 2020-03-12 | $5.13 million | -$5.82 | -$4.34 | -34.26% |
2019-09-30 | 2019-11-06 | $N/A | -$6.80 | -$5.30 | -28.3% |
2019-06-30 | 2019-08-05 | $1.39 million | -$5.80 | -$5.40 | -7.41% |
2019-03-31 | 2019-05-07 | $516000 | -$5.50 | -$5.82 | 5.5% |
2018-12-31 | 2019-03-12 | $312000 | -$6.30 | -$6.46 | 2.48% |
2018-09-30 | 2018-11-06 | $292000 | -$5.50 | -$5.68 | 3.08% |
2018-06-30 | 2018-08-07 | $362000 | -$6.00 | -$5.63 | -6.67% |
2018-03-31 | 2018-05-08 | $154000 | -$6.80 | -$7.04 | 3.45% |
2017-12-31 | 2018-03-13 | $-69000 | -$6.60 | -$6.97 | 5.33% |
2017-09-30 | 2017-11-07 | $126000 | -$7.10 | -$7.40 | 4.05% |
2017-06-30 | 2017-08-08 | $-128000 | -$7.40 | -$6.63 | -11.64% |
2017-03-31 | 2017-05-08 | $128000 | -$8.00 | -$7.04 | -13.68% |
2016-12-31 | 2017-03-13 | $81000 | -$7.40 | -$7.33 | -0.97% |
2016-09-30 | 2016-11-09 | $114000 | -$6.60 | -$6.34 | -4.1% |
2016-06-30 | 2016-08-08 | $101000 | -$6.10 | -$5.80 | -5.17% |
2016-03-31 | 2016-05-09 | $92000 | -$5.60 | -$5.10 | -9.8% |
2015-12-31 | 2016-03-14 | $34000 | -$6.30 | -$4.20 | -50% |
2015-09-30 | 2015-11-09 | $57000 | -$0.51 | -$0.38 | -34.21% |
2015-06-30 | 2015-08-13 | $84000 | -$0.40 | -$0.49 | 18.37% |
2015-03-31 | 2015-05-11 | $107000 | -$0.30 | -$0.30 | 0% |
2014-12-31 | 2015-03-11 | $15000 | -$2.02 | -$0.37 | -445.95% |
Bellicum Pharmaceuticals, Inc (BLCM) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Bellicum Pharmaceuticals, Inc (BLCM) Chart:
Bellicum Pharmaceuticals, Inc (BLCM) News:
Below you will find a list of latest news for Bellicum Pharmaceuticals, Inc (BLCM) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Bellicum Pharmaceuticals, Inc (BLCM) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest BLCM Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 6:12 PM EST | 23 | $1.15 |
Jun 13, 2022 7:33 PM EST | 55 | $1.21 |
Jun 13, 2022 7:43 PM EST | 100 | $1.12 |
Jun 13, 2022 7:55 PM EST | 100 | $1.1 |
Jun 13, 2022 7:56 PM EST | 100 | $1.08 |
Bellicum Pharmaceuticals, Inc (BLCM) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000019/0001358403-20-000019-index.htm |
2019-07-29 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1358403/000000000019011666/0000000000-19-011666-index.htm |
2019-09-06 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000001961719000171/0000019617-19-000171-index.htm |
2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000021545719003311/0000215457-19-003311-index.htm |
2019-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000021545719008301/0000215457-19-008301-index.htm |
2019-08-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000091957419005539/0000919574-19-005539-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000091957420001657/0000919574-20-001657-index.htm |
2020-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000103738920000087/0001037389-20-000087-index.htm |
2020-01-24 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1358403/000110465920006801/0001104659-20-006801-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000114420419007218/0001144204-19-007218-index.htm |
2019-08-22 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1358403/000114420419041148/0001144204-19-041148-index.htm |
2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312518353239/0001193125-18-353239-index.htm |
2019-05-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358403/000119312519139904/0001193125-19-139904-index.htm |
2019-06-06 | DEFR14A | Revised definitive proxy soliciting materials | https://www.sec.gov/Archives/edgar/data/1358403/000119312519166345/0001193125-19-166345-index.htm |
2019-06-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312519176497/0001193125-19-176497-index.htm |
2019-06-24 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358403/000119312519180092/0001193125-19-180092-index.htm |
2019-07-23 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1358403/000119312519200072/0001193125-19-200072-index.htm |
2019-07-23 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358403/000119312519200094/0001193125-19-200094-index.htm |
2019-07-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1358403/000119312519203047/0001193125-19-203047-index.htm |
2019-08-15 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1358403/000119312519222608/0001193125-19-222608-index.htm |
2019-08-16 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1358403/000119312519222902/0001193125-19-222902-index.htm |
2019-08-16 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1358403/000119312519222904/0001193125-19-222904-index.htm |
2019-08-19 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1358403/000119312519224574/0001193125-19-224574-index.htm |
2019-08-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312519224579/0001193125-19-224579-index.htm |
2019-08-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000119312519229442/0001193125-19-229442-index.htm |
2019-11-25 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1358403/000119312519299951/0001193125-19-299951-index.htm |
2019-12-05 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1358403/000119312519307293/0001193125-19-307293-index.htm |
2019-12-05 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1358403/000119312519307300/0001193125-19-307300-index.htm |
2019-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312519318128/0001193125-19-318128-index.htm |
2019-12-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312519326672/0001193125-19-326672-index.htm |
2020-01-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312520007200/0001193125-20-007200-index.htm |
2020-02-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312520026926/0001193125-20-026926-index.htm |
2020-10-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312520281180/0001193125-20-281180-index.htm |
2020-10-30 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1358403/000119312520282788/0001193125-20-282788-index.htm |
2020-11-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000119312520283250/0001193125-20-283250-index.htm |
2018-12-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000120919118063786/0001209191-18-063786-index.htm |
2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000120919118063787/0001209191-18-063787-index.htm |
2018-12-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000120919118063788/0001209191-18-063788-index.htm |
2018-12-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000120919118063791/0001209191-18-063791-index.htm |
2019-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000120919119049227/0001209191-19-049227-index.htm |
2020-01-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000120919120003350/0001209191-20-003350-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000006/0001358403-19-000006-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000007/0001358403-19-000007-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000008/0001358403-19-000008-index.htm |
2019-01-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000009/0001358403-19-000009-index.htm |
2019-01-04 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000010/0001358403-19-000010-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000018/0001358403-19-000018-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000019/0001358403-19-000019-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000020/0001358403-19-000020-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000021/0001358403-19-000021-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000022/0001358403-19-000022-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000023/0001358403-19-000023-index.htm |
2019-02-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000024/0001358403-19-000024-index.htm |
2019-02-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000026/0001358403-19-000026-index.htm |
2019-02-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000028/0001358403-19-000028-index.htm |
2019-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000035/0001358403-19-000035-index.htm |
2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000038/0001358403-19-000038-index.htm |
2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000041/0001358403-19-000041-index.htm |
2019-04-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000044/0001358403-19-000044-index.htm |
2019-04-25 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000047/0001358403-19-000047-index.htm |
2019-04-26 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000050/0001358403-19-000050-index.htm |
2019-04-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000051/0001358403-19-000051-index.htm |
2019-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000056/0001358403-19-000056-index.htm |
2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000058/0001358403-19-000058-index.htm |
2019-05-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000060/0001358403-19-000060-index.htm |
2019-05-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000062/0001358403-19-000062-index.htm |
2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000066/0001358403-19-000066-index.htm |
2019-06-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000069/0001358403-19-000069-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000077/0001358403-19-000077-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000078/0001358403-19-000078-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000079/0001358403-19-000079-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000080/0001358403-19-000080-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000081/0001358403-19-000081-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000082/0001358403-19-000082-index.htm |
2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000083/0001358403-19-000083-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000091/0001358403-19-000091-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000092/0001358403-19-000092-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000093/0001358403-19-000093-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000094/0001358403-19-000094-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000095/0001358403-19-000095-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000096/0001358403-19-000096-index.htm |
2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000097/0001358403-19-000097-index.htm |
2019-07-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000099/0001358403-19-000099-index.htm |
2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000104/0001358403-19-000104-index.htm |
2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000106/0001358403-19-000106-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000111/0001358403-19-000111-index.htm |
2019-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000112/0001358403-19-000112-index.htm |
2019-08-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000114/0001358403-19-000114-index.htm |
2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000121/0001358403-19-000121-index.htm |
2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000123/0001358403-19-000123-index.htm |
2020-01-29 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000004/0001358403-20-000004-index.htm |
2020-02-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000005/0001358403-20-000005-index.htm |
2020-03-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000006/0001358403-20-000006-index.htm |
2020-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000007/0001358403-20-000007-index.htm |
2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000008/0001358403-20-000008-index.htm |
2020-04-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000009/0001358403-20-000009-index.htm |
2020-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000010/0001358403-20-000010-index.htm |
2020-04-17 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000011/0001358403-20-000011-index.htm |
2020-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000012/0001358403-20-000012-index.htm |
2020-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000013/0001358403-20-000013-index.htm |
2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000014/0001358403-20-000014-index.htm |
2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000015/0001358403-20-000015-index.htm |
2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000016/0001358403-20-000016-index.htm |
2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000017/0001358403-20-000017-index.htm |
2020-06-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000018/0001358403-20-000018-index.htm |
2020-06-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000019/0001358403-20-000019-index.htm |
2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000020/0001358403-20-000020-index.htm |
2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000021/0001358403-20-000021-index.htm |
2020-08-06 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000022/0001358403-20-000022-index.htm |
2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000024/0001358403-20-000024-index.htm |
2020-09-16 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000025/0001358403-20-000025-index.htm |
2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000026/0001358403-20-000026-index.htm |
2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1358403/000135840320000027/0001358403-20-000027-index.htm |
2019-01-18 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1358403/000156761919001333/0001567619-19-001333-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000160/0001628280-20-000160-index.htm |
2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000355/0001628280-20-000355-index.htm |
2020-01-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000398/0001628280-20-000398-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000987/0001628280-20-000987-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000991/0001628280-20-000991-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000993/0001628280-20-000993-index.htm |
2020-03-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020003793/0001628280-20-003793-index.htm |
2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020004834/0001628280-20-004834-index.htm |
2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020004836/0001628280-20-004836-index.htm |
2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020004837/0001628280-20-004837-index.htm |
2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020004838/0001628280-20-004838-index.htm |
2020-04-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020004839/0001628280-20-004839-index.htm |
2020-06-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020008801/0001628280-20-008801-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020009546/0001628280-20-009546-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020009547/0001628280-20-009547-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020009548/0001628280-20-009548-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020009549/0001628280-20-009549-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020009550/0001628280-20-009550-index.htm |
2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000162828020009551/0001628280-20-009551-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000170524620000002/0001705246-20-000002-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000170524620000004/0001705246-20-000004-index.htm |
2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000176787720000002/0001767877-20-000002-index.htm |
2020-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000176787720000004/0001767877-20-000004-index.htm |
2019-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000177394419000002/0001773944-19-000002-index.htm |
2020-02-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1358403/000179986920000002/0001799869-20-000002-index.htm |
2019-07-30 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1358403/999999999519001735/9999999995-19-001735-index.htm |
2019-02-19 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1358403/999999999719000428/9999999997-19-000428-index.htm |
2019-04-12 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1358403/999999999719002854/9999999997-19-002854-index.htm |
2019-08-02 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1358403/999999999719006364/9999999997-19-006364-index.htm |
2020-03-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1358403/999999999720001116/9999999997-20-001116-index.htm |
2020-03-03 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1358403/999999999720001117/9999999997-20-001117-index.htm |
Bellicum Pharmaceuticals, Inc (BLCM) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bellicum Pharmaceuticals, Inc (BLCM). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 32%Institutional Ownership: 2390%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-01-02 | Gregory S. Naeve | Chief Business Officer | Buy | 2,031.00 | 15,434.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000009/0001358403-19-000009-index.htm | ||
2019-08-29 | Shane Ward | Sr. VP and General Counsel | Buy | 8,000.00 | 1.23 | 9,821.60 | 18,294.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000114/0001358403-19-000114-index.htm |
2019-08-21 | Richard A. Fair | President and CEO | Buy | 20,000.00 | 0.99 | 19,780.00 | 26,561.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000111/0001358403-19-000111-index.htm |
2019-01-02 | Alan K. Smith | EVP, Technical Operations | Buy | 2,344.00 | 4,431.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000006/0001358403-19-000006-index.htm | ||
2019-01-02 | Rosemary Y. Williams | Principal Accounting Officer | Buy | 1,281.00 | 4,467.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000008/0001358403-19-000008-index.htm | ||
2019-01-03 | Rosemary Y. Williams | Principal Accounting Officer | Buy | 782.00 | 4,766.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000008/0001358403-19-000008-index.htm | ||
2020-03-17 | Richard A. Fair | President and CEO | Buy | 5,000.00 | 4.00 | 19,998.50 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/1358403/000162828020003793/0001628280-20-003793-index.htm |
2019-01-03 | Alan K. Smith | EVP, Technical Operations | Buy | 1,562.00 | 5,110.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000006/0001358403-19-000006-index.htm | ||
2020-01-02 | Rosemary Y. Williams | VP, Finance & PAO | Buy | 1,282.00 | 5,753.00 | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000160/0001628280-20-000160-index.htm | ||
2020-01-03 | Rosemary Y. Williams | VP, Finance & PAO | Buy | 781.00 | 6,051.00 | https://www.sec.gov/Archives/edgar/data/1358403/000162828020000160/0001628280-20-000160-index.htm | ||
2019-09-10 | Richard A. Fair | President and CEO | Buy | 40,000.00 | 1.25 | 50,000.00 | 66,561.00 | https://www.sec.gov/Archives/edgar/data/1358403/000120919119049227/0001209191-19-049227-index.htm |
2020-01-02 | Alan K. Smith | EVP, Technical Operations | Buy | 2,344.00 | 6,865.00 | https://www.sec.gov/Archives/edgar/data/1358403/000170524620000002/0001705246-20-000002-index.htm | ||
2019-11-13 | Jr Joseph Paul Woodard | SVP Clinical & Medical Affairs | Buy | 3,750.00 | 7,064.00 | https://www.sec.gov/Archives/edgar/data/1358403/000177394419000002/0001773944-19-000002-index.htm | ||
2020-01-03 | Aaron E. Foster | Sr VP, Head of Research | Buy | 625.00 | 7,517.00 | https://www.sec.gov/Archives/edgar/data/1358403/000176787720000002/0001767877-20-000002-index.htm | ||
2020-01-03 | Alan K. Smith | EVP, Technical Operations | Buy | 1,563.00 | 7,545.00 | https://www.sec.gov/Archives/edgar/data/1358403/000170524620000002/0001705246-20-000002-index.htm | ||
2020-01-02 | Aaron E. Foster | Sr VP, Head of Research | Buy | 2,500.00 | 7,834.00 | https://www.sec.gov/Archives/edgar/data/1358403/000176787720000002/0001767877-20-000002-index.htm | ||
2019-01-02 | David M. Spencer | Chief Technology Officer | Buy | 2,500.00 | 92,439.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000007/0001358403-19-000007-index.htm | ||
2019-01-03 | David M. Spencer | Chief Technology Officer | Buy | 1,562.00 | 93,059.00 | https://www.sec.gov/Archives/edgar/data/1358403/000135840319000007/0001358403-19-000007-index.htm |